Collagen Cross- Linking for Paediatric Keratoconus.

Open Ophthalmol J

ELZA Institute, Zurich, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland; Faculty of Medicine, University of South California, California, USA.

Published: July 2017

Background: Since the late 1990s corneal crosslinking (CXL) has been proposed as a new treatment option which can stop progression of keratoconus with promising results in adults.

Objective: Keratoconus presents a higher rate and faster progression in paediatric patients and for this reason prompt and effective treatment is essential. Due to its success in adult keratoconus patients, CXL has been recently applied to children in order to stop or slow progression of keratoconus in paediatric patients.

Conclusions: This article will present an update of the literature on the topic of CXL in this age group.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585458PMC
http://dx.doi.org/10.2174/1874364101711010211DOI Listing

Publication Analysis

Top Keywords

progression keratoconus
8
keratoconus
5
collagen cross-
4
cross- linking
4
linking paediatric
4
paediatric keratoconus
4
keratoconus background
4
background late
4
late 1990s
4
1990s corneal
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!